Showing results (201-210 of 3,717) with videos related to
Sort By:
Pageof 372
Pathology|September 22, 2010
The senescence pathway in prostatic carcinogenesisSowmya Sharma, Joo-Shik Shin, Matthew Grimshaw, et al.Pathology|September 22, 2010
Distinct genetic changes characterise multifocality and diverse histological subtypes in papillary thyroid carcinomaLidija Jovanovic, Brett Delahunt, Bryan McIver, et al.Pathology|September 22, 2010
Aurora-A expression, hormone receptor status and clinical outcome in hormone related cancersKakoli Das, Pia Donna Nitullano Lorena, Lai Kuan Ng, et al.Pathology|March 31, 2010
Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN)Eva Karamitopoulou, Inti Zlobec, Luigi Tornillo, et al.Pathology|March 31, 2010
Primary colorectal inflammatory myofibroblastic tumour: a clinicopathological and immunohistochemical study of seven casesHuaiyin Shi, Yan Li, Lixin Wei, et al.Pathology|March 31, 2010
Role of the renal sympathetic nervous system in mediating renal ischaemic injury-induced reductions in renal haemodynamic and excretory functionsIbrahim M Salman, Omar Z Ameer, Munavvar A Sattar, et al.Pathology|March 31, 2010
Three-year longitudinal study of genotypes of Mycobacterium tuberculosis in a low prevalence populationBlanca Gallego, Vitali Sintchenko, Peter Jelfs, et al.Pathology|May 5, 2010
Rare histological patterns of prostatic ductal adenocarcinomaThomas K Lee, Jeremy S Miller, Jonathan I EpsteinPathology|May 5, 2010
Clinicopathological features of prostate cancers detected after an initial diagnosis of 'atypical glands suspicious for cancer'Ming Zhou, Cristina Magi-GalluzziPathology|May 5, 2010
Gleason scoring: a comparison of classical and modified (international society of urological pathology) criteria using nadir PSA as a clinical end pointBrett Delahunt, David S Lamb, John R Srigley, et al.Pageof 372